medical Class II Updated 2022-03-30

Philips Healthcare recalls Azurion systems with software release R2.0.x

Recalled Product

Azurion systems with software release R2.0.x


Hazard / Issue

In the Azurion system, the user can add a new study to a patient by selecting the option "Add Study". The Add Study dialogue box is then displayed where the Patient Type is selected to perform the study. Due to a software defect, when the study is initiated by pressing Start Procedure , the Patient Type changes inadvertently to a Patient Type different than the one selected as shown in the Table below. Patient type is one of the factors involved in the dose control process. The incorrect patient type changes the technique factors to be used by the system without notification to the user.

Issued by

FDA

Distribution: Nationwide (United States)
Lot/Code Info: Model(s) Azurion R2.1
View official government recall

Looking for safe alternatives?

Browse certified-safe products in this category on Amazon →